[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338838-105":59,"doc-detail-338838-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","m6a-methylation-mediated-regulation-of-lncrna-meg3-suppresses-ovarian-cancer-progression-through-mir-885-5p-and-the-vash1-pathway","m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway","","Ovarian cancer remains a major threat to women’s health due to limited early detection and frequent diagnosis at advanced stages or with peritoneal metastasis. This study characterizes LncRNA MEG3 as a tumor suppressor and clarifies how m6A methylation regulates its function. Bioinformatics and functional assays show MEG3 restrains proliferation, migration, and invasion in ovarian cancer cells, largely by modulating the miR-885-5p/VASH1 axis and involving the METTL3–YTHDF2 pathway.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/m6a-methylation-mediated-regulation-of-lncrna-meg3-suppresses-ovarian-cancer-progression-through-mir-885-5p-and-the-vash1-pathway/338838/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/m6a-methylation-mediated-regulation-of-lncrna-meg3-suppresses-ovarian-cancer-progression-through-mir-885-5p-and-the-vash1-pathway/338838.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem in ovarian cancer does the study address?","Question",{"text":112,"@type":113},"The study targets ovarian cancer’s high mortality and the challenge of early detection, where many patients present with advanced-stage disease or peritoneal metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does MEG3 affect ovarian cancer progression?",{"text":117,"@type":113},"MEG3 suppresses ovarian cancer cell proliferation, migration, and invasion, and it reduces the malignant phenotype by influencing the miR-885-5p/VASH1 pathway.",{"name":119,"@type":110,"acceptedAnswer":120},"What role do m6A regulators METTL3 and YTHDF2 play?",{"text":121,"@type":113},"MEG3 is regulated posttranscriptionally through METTL3-mediated m6A modification, and YTHDF2 facilitates MEG3 decay by recognizing the m6A-marked transcript.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338838,1790951868,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Li et al. Journal of Translational Medicine (2024) 22:113  \n[https://doi.org/10.1186/s12967-024-04929-x](https://doi.org/10.1186/s12967-024-04929-x)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nm6A methylation-mediated regulation  \nof LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway  \nYan Li1,2†, Shenghan Lou2†, Jian Zhang2, Shilu Zhao2 and Ge Lou2*  \nAbstract  \nBackground Ovarian cancer poses a serious threat to women’s health. Due to the difficulty of early detection, most patients are diagnosed with advanced-stage disease or peritoneal metastasis. We found that LncRNA MEG3 is a novel tumor suppressor, but its role in tumor occurrence and development is still unclear.  \nMethods We investigated the expression level of MEG3 in pan-cancer through bioinformatics analysis, especially in gynecological tumors. Function assays were used to detect the effect of MEG3 on the malignant phenotype of ovarian cancer. RIP, RNA pull-down, MeRIP-qPCR, actinomycin D test were carried out to explore the m6A methylation-mediated regulation on MEG3 . Luciferase reporter gene assay, PCR and Western blot were implemented to reveal the potential mechanism of MEG3 . We further confirmed the influence of MEG3 on tumor growth in vivo by orthotopic xenograft models and IHC assay.  \nResults In this study, we discovered that MEG3 was downregulated in various cancers, with the most apparent downregulation in ovarian cancer. MEG3 inhibited the proliferation, migration, and invasion of ovarian cancer cells. Overexpression of MEG3 suppressed the degradation of VASH1 by negatively regulating miR-885-5p, inhibiting the ovarian cancer malignant phenotype. Furthermore, we demonstrated that MEG3 was regulated at the posttranscriptional level. YTHDF2 facilitated MEG3 decay by recognizing METTL3-mediated m6A modification. Compared with those injected with vector control cells, mice injected with MEG3 knockdown cells showed larger tumor volumesand faster growth rates.  \nConclusion We demonstrated that MEG3 is influenced by METTL3/YTHDF2 methylation and restrains ovarian cancer proliferation and metastasis by binding miR-885-5p to increase VASH1 expression. MEG3 is expected to become a therapeutic target for ovarian cancer.  \nKeywords MEG3, m6A methylation, VASH1, Ovarian cancer  \n†Yan Li and Shenghan Lou have contributed equally to this work.  \n*Correspondence:  \nGe Lou [louge@ems.hrbmu.edu.cn](louge@ems.hrbmu.edu.cn)  \n1 Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin 150007, Heilongjiang, China  \n2 Department of Gynecology, Harbin Medical University Cancer Hospital, 150 HaPing Road, Nangang District, Harbin 150081, Heilongjiang, China  \nIntroduction  \nEpithelial ovarian cancer causes over 180,000 deaths worldwide each year, and 60% of cases are high-grade serous ovarian cancer (HGSOC) [1]. Ovarian cancer is characterized by a dormant onset, the absence of obvious symptoms in the early stages, and a lack of early diagnostic biomarkers; approximately 75% of patients  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/li","cbCaiqXeKxpfZ9H0","https://ap.wps.com/l/cbCaiqXeKxpfZ9H0","pdf",4019835,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What problem in ovarian cancer does the study address?\",\"answer\":\"The study targets ovarian cancer’s high mortality and the challenge of early detection, where many patients present with advanced-stage disease or peritoneal metastasis.\"},{\"question\":\"How does MEG3 affect ovarian cancer progression?\",\"answer\":\"MEG3 suppresses ovarian cancer cell proliferation, migration, and invasion, and it reduces the malignant phenotype by influencing the miR-885-5p/VASH1 pathway.\"},{\"question\":\"What role do m6A regulators METTL3 and YTHDF2 play?\",\"answer\":\"MEG3 is regulated posttranscriptionally through METTL3-mediated m6A modification, and YTHDF2 facilitates MEG3 decay by recognizing the m6A-marked transcript.\"}]","m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway | PDF",1790026093,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd0e8cabe04a7ec7e05a5c6d7c2a0d55.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b861da28e0d7deafd91d9c2b8d54c10.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f8116d41c3d7b6e2266fdce0dab36d9.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a8bc47a2fc0c3af229d2b61f41e1084.webp",980,1301]